Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Inovio Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 105 | 2 | 108 | +5 |
| Shares | 13.3M | 46.5K | 13.6M | +300.0K (+2.3%) |
| Value | $24.4M | $85.1K | $22.2M | −$2.18M (−9.0%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 103,297 | $168.4K | 0.00% |
| AQR Capital Management LLC | 73,575 | $119.9K | 0.00% |
| Two Sigma Investments, LP | 72,364 | $118.0K | 0.00% |
| SEI Investments Co | 56,806 | $92.6K | 0.00% |
| Concurrent Investment Advisors, LLC | 55,011 | $89.7K | 0.00% |
| CIBC Private Wealth Group, LLC | 40,000 | $58.4K | 0.00% |
| Eqis Capital Management, Inc. | 19,170 | $31.2K | 0.00% |
| Nomura Holdings Inc | 16,871 | $27.5K | 0.00% |
| Price T Rowe Associates Inc | 15,601 | $26.0K | 0.00% |
| Mariner, LLC | 12,856 | $21.0K | 0.00% |
| LPL Financial LLC | 12,197 | $19.9K | 0.00% |
| Russell Investments Group, Ltd. | 4,937 | $8.05K | 0.00% |
| Coldstream Capital Management Inc | 723 | $1.18K | 0.00% |
| Caitong International Asset Management Co., Ltd | 692 | $1.13K | 0.00% |
| MJT & Associates Financial Advisory Group, Inc. | 325 | $530 | 0.00% |
| Rothschild Investment LLC | 60 | $98 | 0.00% |
| 1 North Wealth Services LLC | 41 | $67 | 0.00% |
| S&T Bank | 4 | $7 | 0.00% |
Sold out (13)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| AIGH Capital Management LLC | 654,115 | $1.20M |
| Highbridge Capital Management LLC | 300,000 | $549.0K |
| Wolverine Asset Management LLC | 97,400 | $178.2K |
| Susquehanna Fundamental Investments, LLC | 65,669 | $120.2K |
| Graham Capital Management, L.P. | 62,567 | $114.5K |
| Squarepoint Ops LLC | 51,255 | $93.8K |
| Qube Research & Technologies Ltd | 35,431 | $64.8K |
| Citadel Advisors LLC | 21,728 | $39.8K |
| Alpine Global Management, LLC | 16,906 | $30.9K |
| Engineers Gate Manager LP | 13,502 | $24.7K |
| Northwestern Mutual Wealth Management Co | 193 | $353 |
| Wingate Wealth Advisors, Inc. | 20 | $37 |
| Wood Tarver Financial Group, LLC | 24 | $0 |
Not filed for Q1 2025 yet (2)
Institutions that held Inovio Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 46,491 | $85.1K |
| Householder Group Estate & Retirement Specialist, LLC | 56 | $0 |